GB202108379D0 - Methods for treating a topic dermatitis and related disorders - Google Patents

Methods for treating a topic dermatitis and related disorders

Info

Publication number
GB202108379D0
GB202108379D0 GBGB2108379.5A GB202108379A GB202108379D0 GB 202108379 D0 GB202108379 D0 GB 202108379D0 GB 202108379 A GB202108379 A GB 202108379A GB 202108379 D0 GB202108379 D0 GB 202108379D0
Authority
GB
United Kingdom
Prior art keywords
treating
methods
related disorders
topic dermatitis
dermatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108379.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medlmmune Ltd
Original Assignee
Medlmmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medlmmune Ltd filed Critical Medlmmune Ltd
Priority to GBGB2108379.5A priority Critical patent/GB202108379D0/en
Publication of GB202108379D0 publication Critical patent/GB202108379D0/en
Priority to JP2023575802A priority patent/JP2024522620A/ja
Priority to AU2022289697A priority patent/AU2022289697A1/en
Priority to CA3221119A priority patent/CA3221119A1/en
Priority to IL309053A priority patent/IL309053A/en
Priority to PCT/EP2022/065851 priority patent/WO2022258814A1/en
Priority to TW111121662A priority patent/TW202317184A/zh
Priority to EP22733594.0A priority patent/EP4351641A1/en
Priority to US18/566,712 priority patent/US20250059269A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2108379.5A 2021-06-11 2021-06-11 Methods for treating a topic dermatitis and related disorders Ceased GB202108379D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB2108379.5A GB202108379D0 (en) 2021-06-11 2021-06-11 Methods for treating a topic dermatitis and related disorders
JP2023575802A JP2024522620A (ja) 2021-06-11 2022-06-10 アトピー性皮膚炎及び関連する障害の治療方法
AU2022289697A AU2022289697A1 (en) 2021-06-11 2022-06-10 Methods for treating atopic dermatitis and related disorders
CA3221119A CA3221119A1 (en) 2021-06-11 2022-06-10 Methods for treating atopic dermatitis and related disorders
IL309053A IL309053A (en) 2021-06-11 2022-06-10 Methods for treating atopic dermatitis and related disorders
PCT/EP2022/065851 WO2022258814A1 (en) 2021-06-11 2022-06-10 Methods for treating atopic dermatitis and related disorders
TW111121662A TW202317184A (zh) 2021-06-11 2022-06-10 用於治療異位性皮膚炎和相關障礙之方法
EP22733594.0A EP4351641A1 (en) 2021-06-11 2022-06-10 Methods for treating atopic dermatitis and related disorders
US18/566,712 US20250059269A1 (en) 2021-06-11 2022-06-10 Methods for treating atopic dermatitis and related disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108379.5A GB202108379D0 (en) 2021-06-11 2021-06-11 Methods for treating a topic dermatitis and related disorders

Publications (1)

Publication Number Publication Date
GB202108379D0 true GB202108379D0 (en) 2021-07-28

Family

ID=76954592

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108379.5A Ceased GB202108379D0 (en) 2021-06-11 2021-06-11 Methods for treating a topic dermatitis and related disorders

Country Status (9)

Country Link
US (1) US20250059269A1 (https=)
EP (1) EP4351641A1 (https=)
JP (1) JP2024522620A (https=)
AU (1) AU2022289697A1 (https=)
CA (1) CA3221119A1 (https=)
GB (1) GB202108379D0 (https=)
IL (1) IL309053A (https=)
TW (1) TW202317184A (https=)
WO (1) WO2022258814A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026508149A (ja) * 2023-02-13 2026-03-10 インターベット インターナショナル ベー． フェー． イヌｉｌ－１３に対するイヌ抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0407315D0 (en) 2003-07-15 2004-05-05 Cambridge Antibody Tech Human antibody molecules
AU2006296399B2 (en) 2005-09-30 2011-01-20 Medimmune Limited Interleukin-13 antibody composition
BR112019018022A2 (pt) 2017-03-01 2020-06-02 Medimmune Limited Formulações de anticorpos monoclonais

Also Published As

Publication number Publication date
IL309053A (en) 2024-02-01
TW202317184A (zh) 2023-05-01
CA3221119A1 (en) 2022-12-15
AU2022289697A1 (en) 2023-12-21
JP2024522620A (ja) 2024-06-21
EP4351641A1 (en) 2024-04-17
WO2022258814A1 (en) 2022-12-15
US20250059269A1 (en) 2025-02-20

Similar Documents

Publication Publication Date Title
EP3801744A4 (en) METHOD AND DEVICE FOR TREATING SLEEP-RELATED RESPIRATORY DISORDERS
IL285649A (en) Azepino-indoles and other heterocyclics for the treatment of brain disorders
IL294594A (en) Methods of treating pemphigus
EP3740939A4 (en) APPARATUS AND METHOD FOR OPTIMIZING AND IMPROVING ORDER FLOWS
EP4352079A4 (en) COMPOSITIONS AND METHODS FOR TREATING NEUROFIBROMATIC DISORDERS
IL288655A (en) Preparations and methods for the treatment of central nervous system disorders
GB202105115D0 (en) Systems and methods for machine learning optimization
GB202108379D0 (en) Methods for treating a topic dermatitis and related disorders
EP4023023A4 (en) METHOD AND APPARATUS FOR OVERHEAD REDUCTION IN A DIRECT ACCESS METHOD
SG10202104335VA (en) Pad-temperature regulating apparatus, pad-temperature regulating method, and polishing apparatus
EP3921064A4 (en) METHODS AND APPARATUS FOR TREATING A RESPIRATORY DISORDER
EP3840897C0 (en) DEVICE AND METHOD FOR DESCALING ROLLING STOCK
GB2611137B (en) Control method and control device
IL311066A (en) Treatments for atopic dermatitis
HK40103568A (en) Methods for treating atopic dermatitis and related disorders
HK40082936A (en) Methods for treating atopic dermatitis and related disorders
GB202218093D0 (en) Valve control apparatus and method
GB202213845D0 (en) Input device, controller and method
EP4534370A4 (en) CONTROL METHOD AND CONTROL DEVICE
PL3863178T3 (pl) Układ i sposób sterowania
AU2021903373A0 (en) Methods for treating disorders
HK40039970A (en) Method and device for treating sleep related breathing disorders
IL310559A (en) Methods for treating disorders of the nervous system with antipurinergic substances
GB202003554D0 (en) Spindle engaging apparatus and method
HK40110376A (en) Compositions and methods for treating neurofibromatic disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)